Remimazolam tosylate's long-term sedative properties in ICU patients on mechanical ventilation: effectiveness and safety

Table 2 Details of study drug administration

Variables	Remimazolam (n = 60)	Propofol or midazolam (n = 46)	P-value
Duration of drug use^a, h	56.5 (45.0, 90.0)	59.0 (46.0, 110.0)	0.495
Remifentanil use	58 (96.7)	44 (95.7)	1.000
Dose of remifentanil, μg/h	407.0 (287.3, 483.7)	339.7 (236.8, 444.4)	0.106
Nalbuphine hydrochloride use	50 (83.3)	40 (87.0)	0.785
Dose of nalbuphine hydrochloride, mg/h	7.9 (4.8, 9.4)	6.8 (4.4, 10.3)	0.363

Data are n(%), mean ± SD or median (interquartile range)
^aThe time from the first application of the test drug to the standard of cessation

ISSN: 2047-783X